HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1
2006

HSulf-2: A New Tool for Mobilizing Growth Factors from Heparin

publication 10 minutes Evidence: moderate

Author Information

Author(s): Uchimura Kenji, Morimoto-Tomita Megumi, Bistrup Annette, Li Jessica, Lyon Malcolm, Gallagher John, Werb Zena, Rosen Steven D

Primary Institution: University of California, San Francisco

Hypothesis

Does HSulf-2 modulate the interactions between heparin-binding factors and heparin?

Conclusion

HSulf-2 can disrupt the binding of certain growth factors and chemokines to heparin, suggesting its potential role in regulating their availability.

Supporting Evidence

  • HSulf-2 treatment significantly reduced the binding of VEGF and FGF-1 to heparin.
  • Native Sulf-2 from MCF-7 cells reproduced the effects of recombinant HSulf-2.
  • HSulf-2 can release heparin-bound ligands, enhancing their bioavailability.

Takeaway

HSulf-2 is like a special tool that helps release important proteins from heparin, which is a substance in our body. This can help these proteins do their jobs better.

Methodology

The study used ELISA to measure the binding of growth factors to immobilized heparin before and after treatment with HSulf-2.

Limitations

The study primarily focused on a limited number of growth factors and chemokines, which may not represent all interactions with heparin.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/1471-2091-7-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication